0001209191-16-111756.txt : 20160401 0001209191-16-111756.hdr.sgml : 20160401 20160401172238 ACCESSION NUMBER: 0001209191-16-111756 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160330 FILED AS OF DATE: 20160401 DATE AS OF CHANGE: 20160401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cara Therapeutics, Inc. CENTRAL INDEX KEY: 0001346830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PARROTT DRIVE CITY: SHELTON STATE: CT ZIP: 06484 BUSINESS PHONE: 203-567-1500 MAIL ADDRESS: STREET 1: ONE PARROTT DRIVE CITY: SHELTON STATE: CT ZIP: 06484 FORMER COMPANY: FORMER CONFORMED NAME: Cara Therapeutics Inc DATE OF NAME CHANGE: 20051213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Menzaghi Frederique Ph.D. CENTRAL INDEX KEY: 0001597152 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36279 FILM NUMBER: 161548211 MAIL ADDRESS: STREET 1: C/O CARA THERAPEUTICS, INC. STREET 2: 1 PARROTT DRIVE CITY: SHELTON STATE: CT ZIP: 06484 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-03-30 0 0001346830 Cara Therapeutics, Inc. CARA 0001597152 Menzaghi Frederique Ph.D. C/O CARA THERAPEUTICS, INC. 1 PARROTT DRIVE SHELTON CT 06484 0 1 0 0 VP-Research & Development Employee Stock Option (Right to Buy) 6.00 2016-03-30 4 A 0 65000 0.00 A 2026-03-30 Common Stock 65000 65000 D The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 30, 2016, in each case subject to the Reporting Person's Continuous service (as that term is defined in the Issuer's 2014 Equity Incentive Plan) as of each such date. /s/Darren DeStefano, Attorney-in-Fact 2016-04-01